Author

LB Lindenmaier

Institutions: Oregon State University, Mayo Clinic

Observed institutions: Oregon State University, Mayo Clinic

OpenAlex ID: A5048247268

Abstract P5-05-01: Endoxifen, a novel breast cancer therapy, elicits unique beneficial effects on bone relative to that of other selective estrogen receptor modulators

2013 · JR Hawse, A Gingery, et al. · Cancer Research

Works count: 1

Citation count:

H-index:

I10-index: